Therapy News and Research

RSS

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can significantly reduce the symptoms of a life-limiting eye condition, Benign Essential Blepharospasm (BEB).

17 May 2016

PENTAX Medical releases OPTIVISTA EPK-i7010 Video Processor for more accurate endoscopic in vivo diagnosis

PENTAX Medical launches a world first for endoscopy, the OPTIVISTA EPK-i7010 Video Processor, featuring both digital and optical enhancements, in the European, Middle Eastern & African (EMEA) markets.

From PENTAX Medical Company 17 May 2016

Philips to showcase advanced cardiology solutions at EuroPCR 2016 Congress

Royal Philips today announced its participation in the EuroPCR 2016 Congress in the field of interventional cardiology, taking place in Paris, France, May 17 – 20, 2016.

From Philips Healthcare 17 May 2016

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

Among the women inducted into the University of Kansas Hall of Fame on April 14, 2016, was Carol Fabian, MD. Fabian, a professor of medicine at the University of Kansas Medical Center and director of the Breast Cancer Prevention Center at The University of Kansas Cancer Center, is a nationally recognized oncologist and a pioneer in in the field of breast cancer research.

17 May 2016

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

16 May 2016

Researchers highlight need for more tailored approaches to treating chronic obstructive pulmonary disease

Speakers at the recent REG 2016 Summit highlighted the need for more research into the nature and effectiveness of treatment for COPD (Chronic Obstructive Pulmonary Disease) in a real-world environment.

16 May 2016

WHO guidelines on the management of health complications from female genital mutilation

Health workers across the world now need to be prepared to provide care to girls and women who have undergone FGM. But, health workers are often unaware of the many negative health consequences of FGM and many remain inadequately trained to recognize and treat them properly. As a result, many women may suffer needlessly from physical and mental health consequences due to FGM.

16 May 2016

Amadeus invests in Inotec’s advanced woundcare technology - NATROX™

Amadeus Capital Partners, the global technology investor, has today announced an investment in Inotec AMD, a maker of mobile medical devices designed to heal chronic, hypoxic wounds that afflict millions of sufferers around the world every year. As more than 90% of wounds suffer from a lack of oxygen, the launch of NATROX™ addresses this serious concern with a simple, cost-effective application which treats a broad spectrum of chronic health problems.

16 May 2016

GammaCore both effective and cost effective for the treatment of cluster headache

A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further economic benefits would have been found had reduced visits to clinics been taken into account.

16 May 2016

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.

16 May 2016

Altered coagulation caused by HIV virus linked to increased risk of non-AIDS diseases

With more than 36.9 million people infected globally, HIV continues to be a major public health issue. Those living with the virus are at an increased risk for other non-AIDS diseases, such as cardiovascular disease and cancer, and though it's not entirely clear why, this has been associated with inflammation and abnormal blood clotting.

13 May 2016

Novel ‘Catch It’ smartphone app can help people manage their problems

In a joint project between the Universities of Liverpool and Manchester researchers have examined the initial trial of a smartphone application designed to help people manage their problems.

13 May 2016

Study finds no link between weekend staffing levels and patient deaths

The ‘weekend effect’ – that patients admitted to hospital over the weekend are at an increased risk of death – overshadows a much more complex pattern of weekly changes in quality of care, which are unlikely to be addressed by simply increasing the availability of hospital doctors on Saturdays and Sundays, according to two new studies published in The Lancet.

13 May 2016

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today announced the start of patient enrollment in a long-term safety study (trial 012) of the company’s continuously administered subcutaneous levodopa/carbidopa formulation used in both ND0612H and ND0612L.

13 May 2016

On-treatment relapse drives disability accrual in MS patients

Frequent relapse activity appears to be a key driver of disability accrual in patients with relapse-onset multiple sclerosis, indicates a study of patients receiving first-line injectable disease-modifying treatment.

13 May 2016

ISSCR releases updated guidelines for stem cell research, development of new therapies

The International Society for Stem Cell Research, the world's largest professional organization of stem cell scientists, today released newly updated guidelines for stem cell research and the development of new clinical therapies.

13 May 2016

New E-Vac therapy may be promising treatment option for GI leaks

Gastroenterologists on the medical staff at Baylor University Medical Center at Dallas are evaluating a new procedure for patients with gastrointestinal (GI) leaks and perforations, a complication that can result from laparoscopic surgery on the esophagus, stomach and small intestines—and outcomes have been promising.

13 May 2016

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Up to now, research into pollen allergies has largely focused on allergens - those components of pollen that trigger hypersensitivity reactions. When it comes into contact with the nasal mucous membrane, however, pollen releases a host of other substances in addition to allergens.

13 May 2016

Gene therapy shows promise in treating glioblastoma

A team from the International School for Advanced Studies in Trieste has obtained very promising results by applying gene therapy to glioblastoma.

13 May 2016

'Weekend effect’ may contribute to worsening availability of donor kidneys in the U.S

Investigators have uncovered a "weekend effect" contributing to the worsening availability of donor kidneys in the United States. They found that kidneys that would normally be made available for transplantation were less likely to be procured from donors over the weekend (89.5% on the weekend vs. 90.2% during the week).

13 May 2016

Therapy News and Research

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

PENTAX Medical releases OPTIVISTA EPK-i7010 Video Processor for more accurate endoscopic in vivo diagnosis

Philips to showcase advanced cardiology solutions at EuroPCR 2016 Congress

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Researchers highlight need for more tailored approaches to treating chronic obstructive pulmonary disease

WHO guidelines on the management of health complications from female genital mutilation

Amadeus invests in Inotec’s advanced woundcare technology - NATROX™

GammaCore both effective and cost effective for the treatment of cluster headache

Pluristem completes enrollment in Phase II intermittent claudication trial

Altered coagulation caused by HIV virus linked to increased risk of non-AIDS diseases

Novel ‘Catch It’ smartphone app can help people manage their problems

Study finds no link between weekend staffing levels and patient deaths

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

On-treatment relapse drives disability accrual in MS patients

ISSCR releases updated guidelines for stem cell research, development of new therapies

New E-Vac therapy may be promising treatment option for GI leaks

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Gene therapy shows promise in treating glioblastoma

'Weekend effect’ may contribute to worsening availability of donor kidneys in the U.S

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News